Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     ATC     Antiinfectives for Systemic Use     Vaccines     Animal Vaccines    

Global Inactivated vaccines Market Research Report

Inactivated vaccines and Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines, Sub-unit vaccines and Other Vaccine technology adds up to total Animal Vaccines market.

Inactivated vaccines can be segmented by Types, Geographies, MacroIndicators, Companies and Products. Types of this market are Preventive and Therapeutic. Geographies of this market are North America, Europe, Asia and Rest of World. MacroIndicators of this market are Healthcare Expenditure. Companies of this market are Pfizer Inc, Sanofi, Merck & Co., Inc., Virbac, Bayer Healthcare and Other Companies. Products of this market are Livestock, Porcine, Poultry, Companion animal vaccines, Equine and Aquaculture.

 

Key Questions Answered

  • What are market estimates and forecasts; which of Inactivated vaccines markets are doing well and which are not?
  • What is the competitive landscape; How companies like Pfizer Inc, Sanofi and Merck & Co., Inc. doing in Inactivated vaccines?
  •  

    What makes our report unique?

    • This report provides market sizing and forecast for the Inactivated vaccines market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
    • The report provides deep dive competitive landscape covering the top players such as Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
    • The reports provides benchmarking insight on the top players Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
    • The report provide competitive intelligence on Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
    •  

      Audience for this report

      • Global Inactivated vaccines companies
      • Manufacturing Companies
      • Traders, distributors, and suppliers
      • Governmental and research organizations
      • Associations and industry bodies
      • Technology providers
show more
PRODUCT TITLE PUBLISHED
North American Inactivated vaccines Market North American Inactivated vaccines Market
The North American Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $627 million in 2013 and expected to be $818 million by 2018 at a CAGR of 5.5%. Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
European Inactivated vaccines Market European Inactivated vaccines Market
The European Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $744 million in 2013 and expected to be $1026 million by 2018 at a CAGR of 6.6%. European Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Asian Inactivated vaccines Market Research Report Asian Inactivated vaccines Market Research Report
The Asian Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $333 million in 2013 and expected to be $610 million by 2018 at a CAGR of 12.9%. Asian Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
3 of 3 items
3 reports | Show
Connect With Us
US/CAN : +1-888-502-0539